IHE Pharmacy addresses information sharing, workflow and patient care in both community and hospital pharmacy settings.
Vision and Mission
Our vision: An e-Medication landscape which is integrated and interoperable
Our mission: All exchanging of medication-related information is enabled by leveraging profiles based on current and well-accepted standards
For sponsors and supports of the committee, refer to Supporters and Endorsements
IHE Pharmacy Domain Committees
There are two committees :
Supplements for Trial Implementation
The IHE Pharmacy Technical Committee invites organizations to begin development work based on the following supplements to the forthcoming Pharmacy Technical Framework.
These trial implementation profiles are available for testing at IHE Connectathons since April 2011.
All the up-to-dated informations on the profiles are available on the ihe.net website @ http://ihe.net/Technical_Frameworks/#pharmacy
Comments and implementer feedback on all documents can be submitted to the Pharmacy (PHARM) Public Comment Form.
The IHE Pharmacy domain undergoes constant strategic planning to evaluate its vision, mission and strategic goals.
Given the charter of the PHARM domain, many years or "cycles" of work will be required to address the device integration needs that have been identified.
The Planning Committee has created and maintains a road map for when the group will address various areas. This document outlines goals and plans over the next 5-10 years and shall support fulfilling the strategic goals of the committee.
Please see the current document at: Roadmap
See past roadmaps here: Past roadmaps
The Technical Committee is currently working on a new version of a candidate Integration Profile and 1 white papers:
- the CMPD profile Basic Community Pharmacy Integration Profile with XDW
- publish & pull prescriptions, access to dispensed medication & pharmaceutical advice
- a white paper on the medication supply chain inside hospitals
- to extend the Basic Hospital Pharmacy Integration Profile
|Dec 2011||Treviso, Italy||XDW Conference|
|Feb 2012||Las Vegas||HIMSS|
|Jun 2012||Budapest||EAHP GA|
|Oct 2012||Copenhagen||epSOS WP3.D, eP Semantic Interoperability Workshop|
|Sep 2013||Dublin/Ireland||FIP (“International Federation of Pharmacy”)|
|Sep 2013||Sendai/Japan||International congress of Japanese Pharmacists association|
|Sep 2013||Tokyo/Japan||Franco-Japanese Society of Pharmacists|
|Sep 2013||Kyoto/Japan||University of Medicine and Pharmacy|
|Jun 2014||Athens||European Commission eHealth Forum|
|Oct 2014 22/23||Kassel||HL7/IHE Germany Annual meeting (Jahrestagung)||Presentation and educational workshop|
|2015 April 24||Luxembourg||MedeTel Event||Title: “Integrating Hospital Pharmacy and Community Pharmacy – Facing the Interoperability Challenge with IHE Profiles”|
Timeline : 2021-2022 Development Cycle Milestones
According to IHE Pharmacy Domain Milestone Dates
Dates and times are Central European Time (CET : Paris, Brussels, Amsterdam, Vienna).
|September 3rd, 2021: Start of season 2021/2022|
|September||Call for proposals||September 3rd, 2021|
|October||Call for proposals Deadline||October 1st, 2021|
|January||Test implementations at Connectathon (North America)|
|March||Test implementations at Connectathon (Europe)|
|April||F2F Meeting||April 27-28, 2022|
|May||Publish work-items for Public Comment||April 30, 2022|
|June||Public Comment - Deadline||June 3rd, 2022|
|June||Publication of CPs - released for Ballot||June 29, 2022||www.ihe.net|
|July||Ballot Start||July 1st, 2022|
|June||F2F meeting : Final review of NWIs, approved for ballot||June 28-29, 2022|
|July||IHE Pharmacy Webinar 2022||July||WebEx Webinar|
|August||Ballot - Deadline||August 1st, 2022|
|August||Publication of Trial Implementation Supplements||August 20, 2020||www.ihe.net|
|August||Technical Frameworks Released||August 26, 2022|
Supporters and Endorsements
IHE Pharmacy is supported or endorsed by the following organizations:
- EAHP [pending)
Request to join the IHE Pharmacy discussion group here.
This page is based on the Domain Template.